Caso sector Pharma


  • 20 May 2015
  • Neuro-discovery, Neuro-experience, Sales reconduction

Sales Growth in Mature Products and New Launches

Spanish pharmaceutical group leader at national and international level


Renewal of sales of mature products -both for patent expiration and obsolescence by new formulas- that, while had important falls in sales, still posed a significant revenue for the company.


KBC made a neuro-discovery and a whole neuro-experiential development for several products in maturity phase, which was later adopted as a methodology for products at that stage of their life cycle. Subsequently made a similar job for maximizing the reach and effectiveness in launching a new product.


1- Rebound/significant annual increase in sales of products with important turnovers but decreases (for their maturity / obsolescence) in previous years.
2- Substantial increase in sales in a new product launch in comparison with best previous experiences.
3- Significant reduction in the Time-To-Market and marketing and trade/commercial costs, both in launching new products and in the re-launch of existing and/or mature ones.

En utilizamos cookies propias y de terceros para ofrecer un mejor servicio. Si continúa navegando consideramos que acepta su uso. Encontrará más información en nuestra política de cookies para desactivar las cookies. Más información sobre las cookies

Los ajustes de cookies de esta web están configurados para "permitir cookies" y así ofrecerte la mejor experiencia de navegación posible. Si sigues utilizando esta web sin cambiar tus ajustes de cookies o haces clic en "Aceptar" estarás dando tu consentimiento a esto.